KEGG analysis of these 21 targets showed that bioactive ingredients of formononetin were involved in endocrine resistance pathways, microRNAs in cancer pathway, C-type lectin receptor signaling pathway, estrogen signaling pathway, and cellular senescence pathway. This evidence concerns the gene CLEC4D and cancer.